GENERATE BIOMEDICINES: EXISTING CASH, CASH EQUIVALENTS, AND MARKETABLE SECURITIES SUFFICIENT TO FUND CURRENT OPERATING PLAN INTO H1 2028

Reuters · 2d ago

Please log in to view news